2014
DOI: 10.1016/j.clgc.2013.09.004
|View full text |Cite
|
Sign up to set email alerts
|

Nephron-Sparing Surgery for Renal Tumors Measuring More Than 7 cm: Morbidity, and Functional and Oncological Outcomes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
12
0
2

Year Published

2014
2014
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(14 citation statements)
references
References 30 publications
(52 reference statements)
0
12
0
2
Order By: Relevance
“…For SRM, similar complication rates of PN and RN could be shown 5 . With increasing tumor complexity, increasing rates of high‐grade complications, for PN of approximately 20%, have been described 9,10,12,25 . Serious complications of PN are urinomas and arteriovenous fistulas 7,8,12,13 .…”
Section: Discussionmentioning
confidence: 90%
“…For SRM, similar complication rates of PN and RN could be shown 5 . With increasing tumor complexity, increasing rates of high‐grade complications, for PN of approximately 20%, have been described 9,10,12,25 . Serious complications of PN are urinomas and arteriovenous fistulas 7,8,12,13 .…”
Section: Discussionmentioning
confidence: 90%
“…Preservation of renal function is a driving force for PN. When compared with RN for T2 renal masses or larger, PN demonstrates long‐term renal function preservation while maintaining a high cancer‐specific survival rate . New‐onset kidney disease was more prevalent after RN in comparison with PN (40.2% vs 16.3%) .…”
Section: Discussionmentioning
confidence: 99%
“…When renal cortical tumors are small and low stage, the opportunity for surgical cure remains high even for clear cell RCC with aggressive features. Although Fuhrman grade III–IV and microvascular invasion clearly remain very strong predictors of kidney cancer–specific mortality [2327], they may not have the same level of significance when a nomogram is applied to a population with tumors that are smaller and lower stage and have yet to metastasize. The result of these factors is reflected in the significantly higher actual 5-yr RFP of this cohort when compared with the original cohort (96.7% vs 80.9%).…”
Section: Discussionmentioning
confidence: 99%